| |
| |
|
| Insider
Information: |
Tagliaferri Mary |
| Relationship: |
Director |
| City: |
Emeryville |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
9,883,137 |
|
|
Indirect Shares
|
57,000 |
|
|
| Direct
Value |
$413,292 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,940,137 |
|
|
| Total
Value |
$413,292 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
BioNovo Inc |
BNVIQ |
VP, CRO, Treasurer, Se... |
2010-02-23 |
9,566,094 |
2010-02-23 |
57,000 |
Premium* |
|
|
Enzo Biochem Inc |
ENZ |
Director |
2024-01-31 |
312,383 |
2022-04-27 |
0 |
Premium* |
|
|
Y-Mabs Therapeutics Inc |
YMAB |
Director |
2024-03-12 |
4,660 |
2024-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YMAB |
Y-Mabs Therapeutics Inc |
Director |
– • – |
2024-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,660 |
4,660 |
0 |
- |
|
| ENZ |
Enzo Biochem Inc |
Director |
– • – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
79,365 |
312,383 |
0 |
- |
|
| ENZ |
Enzo Biochem Inc |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
75,188 |
155,917 |
0 |
- |
|
| ENZ |
Enzo Biochem Inc |
Director |
– • – |
2022-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
41,666 |
80,729 |
0 |
- |
|
| ENZ |
Enzo Biochem Inc |
Director |
– • – |
2022-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
39,063 |
39,063 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, CRO, Treasurer, Secretary |
• • • |
2010-02-23 |
4 |
B |
$0.56 |
$9,520 |
D/D |
17,000 |
9,566,094 |
3.15 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, Chief Regulatory Officer |
• • • |
2009-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
9,549,094 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, Chief Regulatory Officer |
• • • |
2009-07-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,700) |
57,000 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, CRO, Treasurer, Secretary |
• • • |
2009-06-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
25,000 |
60,700 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, Chief Regulatory Officer |
• • • |
2009-06-02 |
4 |
S |
$0.45 |
$4,533 |
D/D |
(10,000) |
9,570,394 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, CRO, Treasurer, Secretary |
• • • |
2008-02-26 |
4/A |
GD |
$0.00 |
$0 |
I/I |
16,000 |
35,700 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, CRO, Treasurer, Secretary |
• • • |
2007-03-23 |
4/A |
GD |
$0.00 |
$0 |
I/I |
1,100 |
19,700 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
President, Chief Med. Offcr. |
• • • |
2007-03-06 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,600 |
9,601,094 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, CRO, Treas, Secretary |
• • • |
2007-01-29 |
4 |
S |
$1.60 |
$400,000 |
D/D |
(250,000) |
9,601,094 |
0 |
- |
|
| BNVIQ |
BioNovo Inc |
VP, CRO, Treas, Sec & Dir |
• • • |
2006-06-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,000 |
7,500 |
|
- |
|
| BNVIQ |
BioNovo Inc |
VP, CRO, Treas, Sec & Dir |
• • • |
2006-06-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
9,851,094 |
|
- |
|
| BNVIQ |
BioNovo Inc |
officerTitle |
• • • |
2006-01-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
9,866,094 |
|
- |
|
| BNVIQ |
BioNovo Inc |
VP, Chf Reg Off, Treas and Sec |
• – • |
2005-04-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,891,094 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
